Join
Live feed
·
INSIDERFilingvia Quantisnow
Elevation Oncology Inc. logo

CHIEF SCIENTIFIC OFFICER Dornan David converted options into 9,375 shares and covered exercise/tax liability with 4,152 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELEV· Elevation Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELEV (Elevation Oncology Inc.) and more on Quantisnow.